DLX3 (gene)
DLX3 is a gene that encodes a member of the Distal-less (Dlx) family of transcription factors in humans. These transcription factors are involved in the regulation of embryonic development and are characterized by a conserved DNA-binding homeodomain. The DLX3 protein plays a critical role in the development of the placenta, bones, teeth, and hair. Mutations in the DLX3 gene are associated with several genetic disorders, including Tricho-Dento-Osseous Syndrome (TDO) and Amelogenesis Imperfecta (AI), which affect the development of teeth and hair, and bone density, respectively.
Function[edit | edit source]
DLX3 is part of the DLX gene family, which is involved in forebrain and limb development, as well as in the differentiation of specific cell types. In the context of epidermal differentiation, DLX3 is known to regulate the expression of genes critical for keratinocyte differentiation and is essential for the proper development of the epidermis and hair follicles. In the skeletal system, DLX3 contributes to bone formation and mineralization, acting as a key regulator in the osteoblast differentiation process.
Genetic and Clinical Significance[edit | edit source]
Mutations in the DLX3 gene can lead to Tricho-Dento-Osseous Syndrome, a condition characterized by abnormalities in hair, teeth, and bone density. Individuals with TDO may have brittle or discolored teeth, sparse hair, and increased bone density. Another condition linked to DLX3 mutations is Amelogenesis Imperfecta, which primarily affects the enamel of teeth, leading to tooth discoloration, increased tooth wear, and sensitivity.
Molecular Biology[edit | edit source]
The DLX3 gene is located on chromosome 17 (17q21.33) and consists of several exons that encode the DLX3 protein. This protein binds to DNA through its homeodomain, regulating the transcription of target genes involved in cell differentiation and development. The regulation of DLX3 expression is critical for the temporal and spatial patterns of development in various tissues, including the placenta and craniofacial structures.
Research Directions[edit | edit source]
Research on DLX3 continues to uncover its roles in development and disease. Studies are exploring its potential involvement in other developmental processes and its interaction with other genes and proteins within the DLX family and beyond. Understanding the mechanisms by which DLX3 mutations lead to specific clinical manifestations may provide insights into novel therapeutic approaches for related disorders.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD